GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fangzhou Inc (HKSE:06086) » Definitions » Gross Margin %

Fangzhou (HKSE:06086) Gross Margin % : 18.08% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Fangzhou Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Fangzhou's Gross Profit for the six months ended in Dec. 2024 was HK$267 Mil. Fangzhou's Revenue for the six months ended in Dec. 2024 was HK$1,478 Mil. Therefore, Fangzhou's Gross Margin % for the quarter that ended in Dec. 2024 was 18.08%.


The historical rank and industry rank for Fangzhou's Gross Margin % or its related term are showing as below:

HKSE:06086' s Gross Margin % Range Over the Past 10 Years
Min: 12.49   Med: 18.17   Max: 20.02
Current: 19.06


During the past 4 years, the highest Gross Margin % of Fangzhou was 20.02%. The lowest was 12.49%. And the median was 18.17%.

HKSE:06086's Gross Margin % is ranked worse than
84.24% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 40.605 vs HKSE:06086: 19.06

Fangzhou had a gross margin of 18.08% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Fangzhou was 0.00% per year.


Fangzhou Gross Margin % Historical Data

The historical data trend for Fangzhou's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fangzhou Gross Margin % Chart

Fangzhou Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Gross Margin %
12.49 17.27 20.02 19.06

Fangzhou Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Margin % Get a 7-Day Free Trial - 19.13 21.03 20.07 18.08

Competitive Comparison of Fangzhou's Gross Margin %

For the Pharmaceutical Retailers subindustry, Fangzhou's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fangzhou's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fangzhou's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Fangzhou's Gross Margin % falls into.


;
;

Fangzhou Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Fangzhou's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=550.9 / 2890.581
=(Revenue - Cost of Goods Sold) / Revenue
=(2890.581 - 2339.725) / 2890.581
=19.06 %

Fangzhou's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=267.3 / 1478.242
=(Revenue - Cost of Goods Sold) / Revenue
=(1478.242 - 1210.905) / 1478.242
=18.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fangzhou  (HKSE:06086) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fangzhou had a gross margin of 18.08% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Fangzhou Gross Margin % Related Terms

Thank you for viewing the detailed overview of Fangzhou's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fangzhou Business Description

Traded in Other Exchanges
N/A
Address
4th Street, Floor 1-2, Building S, Kehui Jingu, No. 99, Science Avenue, Luogang Science City, Huangpu District, Guangdong Province, Guangzhou, CHN
Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.
Executives
Asia Tech Holdings Limited 2201 Interest of corporation controlled by you
Vistra Trust (hong Kong) Limited 2301 Trustee
Crescent China Investment Management Ltd. 2102 Investment manager
Hand David Mckee 2201 Interest of corporation controlled by you
Rojanavanichkul Danai 2201 Interest of corporation controlled by you
Veneto Holdings Ltd. 2201 Interest of corporation controlled by you
Tech-med Cayman Iii Ltd. 2201 Interest of corporation controlled by you
Tech-med Investments (s) Pte. Ltd. 2101 Beneficial owner
Cp Pharmatech Singapore Pte. Ltd. 2101 Beneficial owner
Asia Tech Investments Ltd. 2101 Beneficial owner
Crescent Acso Investment Management Ltd 2201 Interest of corporation controlled by you
Crescent Trident Singapore Pte. Ltd. 2101 Beneficial owner
Xie Fangmin 2201 Interest of corporation controlled by you
Zhou Feng 2201 Interest of corporation controlled by you
Fangrong Management Limited 2101 Beneficial owner

Fangzhou Headlines

No Headlines